| Identification | Back Directory | [Name]
4-[4-Fluoro-1-(1-methylethyl)-1H-imidazo[4,5-c]pyridin-6-yl]-N-[5-[4-(1-methylethyl)-1-piperazinyl]-2-pyridinyl]-2-pyrimidinamine | [CAS]
2531748-80-6 | [Synonyms]
4-[4-Fluoro-1-(1-methylethyl)-1H-imidazo[4,5-c]pyridin-6-yl]-N-[5-[4-(1-methylethyl)-1-piperazinyl]-2-pyridinyl]-2-pyrimidinamine | [Molecular Formula]
C25H30FN9 | [MOL File]
2531748-80-6.mol | [Molecular Weight]
475.57 |
| Hazard Information | Back Directory | [Uses]
CDK2/4/6-IN-2 is a CKD2/4/6 inhibitor, with IC50 values less than 1 μM, 10 nM, 100 nM respectively[1]. | [IC 50]
CDK2; CDK4; CDK6 | [References]
[1] Hu Zhilong, et al. Preparation of pyrimidine derivatives and related heterocycles as CDK inhibitors for the treatment of cancer. Patent. WO2020224568 A1 |
|
|